/4978.T
4978.T Stock - ReproCELL Incorporated
Healthcare|BiotechnologyJPX
$141.00+0.71%
+$1.00 (+0.71%) • Dec 24
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.10
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.98
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $155.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4978.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$139.59 – $142.41
TARGET (TP)$162.15
STOP LOSS$129.72
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.55
52W High$277.00
52W Low$98.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.98B | $2.43B | $2.95B | $2.23B | $1.29B |
| Gross Profit | $1.65B | $1.12B | $1.14B | $803.44M | $482.70M |
| Gross Margin | 55.3% | 46.2% | 38.6% | 36.0% | 37.5% |
| Operating Income | $-130,408,999 | $-409,293,000 | $-356,224,000 | $-647,127,000 | $-1,048,046,000 |
| Net Income | $103.25M | $-31,415,000 | $-305,313,000 | $-575,094,000 | $-812,572,000 |
| Net Margin | 3.5% | -1.3% | -10.3% | -25.7% | -63.2% |
| EPS | $1.11 | $-0.37 | $-3.62 | $-7.57 | $-11.38 |
Company Overview
ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4978.TBeat Rate
72%
Last 18 quarters
Avg Surprise
-24.4%
EPS vs Estimate
Beats / Misses
13/5
Last 12 quarters
Latest EPS
$-1.92
Q4 2025
EPS Surprise History
Q4 23
+93.5%
$-0.14vs$-2.14
Q1 24
+85.1%
$-0.14vs$-0.94
Q2 24
+74.9%
$-0.91vs$-3.62
Q3 24
-153.5%
$-0.84vs$1.57
Q4 24
+75.0%
$-0.31vs$-1.24
Q1 25
+329.4%
$0.78vs$-0.34
Q2 25
+305.7%
$1.42vs$0.35
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $-1.92 | — | — |
Q2 2025 | May 14, 2025 | $0.35 | $1.42 | +305.7% | ✓ BEAT |
Q1 2025 | Feb 13, 2025 | $-0.34 | $0.78 | +329.4% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-1.24 | $-0.31 | +75.0% | ✓ BEAT |
Q3 2024 | Aug 13, 2024 | $1.57 | $-0.84 | -153.5% | ✗ MISS |
Q2 2024 | May 13, 2024 | $-3.62 | $-0.91 | +74.9% | ✓ BEAT |
Q1 2024 | Feb 9, 2024 | $-0.94 | $-0.14 | +85.1% | ✓ BEAT |
Q4 2023 | Nov 10, 2023 | $-2.14 | $-0.14 | +93.5% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-0.23 | $0.85 | +469.6% | ✓ BEAT |
Q2 2023 | May 12, 2023 | $-0.35 | $-3.13 | -794.3% | ✗ MISS |
Q1 2023 | Feb 10, 2023 | $-0.94 | $-1.29 | -37.2% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $-1.24 | $0.31 | +125.0% | ✓ BEAT |
Q3 2022 | Aug 10, 2022 | $-1.46 | $0.51 | +134.9% | ✓ BEAT |
Q2 2022 | May 13, 2022 | $0.22 | $-2.74 | -1345.5% | ✗ MISS |
Q1 2022 | Feb 10, 2022 | $-9.22 | $-1.95 | +78.9% | ✓ BEAT |
Q4 2021 | Nov 12, 2021 | $-3.43 | $-1.09 | +68.2% | ✓ BEAT |
Q3 2021 | Aug 13, 2021 | $-2.91 | $-1.70 | +41.6% | ✓ BEAT |
Q2 2021 | May 12, 2021 | — | $-2.16 | — | — |
Q1 2021 | Feb 12, 2021 | $-3.08 | $-4.09 | -32.8% | ✗ MISS |
Q4 2020 | Nov 12, 2020 | $-3.81 | $-2.21 | +42.0% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about 4978.T
What is 4978.T's current stock price?
ReproCELL Incorporated (4978.T) is currently trading at $141.00 per share. The stock has moved +0.71% today.
What is the analyst price target for 4978.T?
No analyst price targets are currently available for this stock.
What sector is ReproCELL Incorporated in?
ReproCELL Incorporated operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4978.T's market cap?
ReproCELL Incorporated has a market capitalization of $13.35 billion, making it a large-cap company.
Does 4978.T pay dividends?
No, ReproCELL Incorporated does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector366A.T
Wellness Communications Corporation
$2209.00
Mkt Cap: $13.8B
3902.T
Medical Data Vision Co., Ltd.
$1686.00
Mkt Cap: $63.8B
4320.T
CE Holdings Co., Ltd.
$1050.00
Mkt Cap: $17.5B
4575.T
CanBas Co., Ltd.
$801.00
Mkt Cap: $15.8B
4579.T
RaQualia Pharma Inc.
$965.00
Mkt Cap: $23.6B
4588.T
Oncolys BioPharma Inc.
$903.00
Mkt Cap: $22.4B
4599.T
StemRIM
$259.00
Mkt Cap: $16.1B
7743.T
SEED Co.,Ltd.
$564.00
Mkt Cap: $17.1B
7774.T
Japan Tissue Engineering Co., Ltd.
$486.00
Mkt Cap: $19.7B
7776.T
CellSeed Inc.
$234.00
Mkt Cap: $8.1B
Explore stocks similar to 4978.T for comparison